Lataa...
HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications
Chronic hepatitis B virus (HBV) infection represents a worldwide public health concern with approximately 250 million people chronically infected and at risk of developing liver cirrhosis and hepatocellular carcinoma. Nucleos(t)ide analogues (NUC) are the most widely used therapies for HBV infection...
Tallennettuna:
| Julkaisussa: | Int J Mol Sci |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6600394/ https://ncbi.nlm.nih.gov/pubmed/31195619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20112754 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|